A significant breakthrough in cancer investigation is arising with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor protector protein is frequently disabled in several types of tumors, leading https://socialfactories.com/story7532418/nanobodies-revive-the-p53-protein-new-new-pathway-for-malignant-management